A Promise in the Treatment of Endometriosis: An Observational Cohort Study on Ovarian Endometrioma Reduction by N-Acetylcysteine
Table 1
Characteristics of patients.
Controls ()
Treated ()
Age (years)
32.9 ± 6.5
32.5 ± 7.3
ns
Weight (kg)
57.8 ± 7.2
60.2 ± 13.3
ns
Height (cm)
164.3 ± 5.8
163.8 ± 6.8
ns
BMI
21.4 ± 2.5
22.5 ± 4.9
ns
Past hormonal therapy ()
22
28
ns
Pregnancy desire ()
14
15
ns
Parity ()
0
29
35
ns
1
11
10
ns
≥2
5
2
ns
Pregnancies post ()a
6
8
ns
Infertility
10
13
ns
Previous surgery for endometriosis
17
12
ns
Deep infiltrating lesions
4
2
ns
Dysmenorrhea (1–10 VAS)
7.18 ± 2.58 ()
6.43 ± 3.39 ()
ns
Dyspareunia (1–10 VAS)
2.76 ± 3.27 ()
2.83 ± 3.19 ()
ns
Chronic pelvic pain (1–10 VAS)
2.07 ± 3.57 ()
2.47 ± 3.82 ()
ns
Patients with more than 1 cyst
21b
20c
ns
()
()
Cyst size
Average diameter (mm)
31.6 ± 18.4
26.9 ± 14.9
ns
Average volume (mL)
35.1 ± 62.6
20.4 ± 31.3
ns
Only 1 pregnancy in the treated group was reported during the 3 months. All other pregnancies occurred after the observation period and were reported by the patients. b: 2 cysts; : 3 cysts; : 5 cysts. c: 2 cysts; : 3 cysts; : 4 cysts.
